Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Open access

Abstract

AIMS: Impact of changes of treatments on outcomes in ST-elevation myocardial infarction (STEMI) patients in real-life health care has not been documented. METHODS AND RESULTS: All STEMI cases (n = 105.674) registered in the nation-wide SWEDEHEART registry between 1995 and 2014 were included and followed for fatal and non-fatal outcomes for up to 20 years. Most changes in treatment and outcomes occurred from 1994 to 2008. Evidence-based treatments increased: reperfusion from 66.2 to 81.7%; primary percutaneous coronary intervention: 4.5 to 78.0%; dual antiplatelet therapy from 0 to 89.6%; statin: 14.1 to 93.6%; beta-blocker: 78.2 to 91.0%, and angiotensin-converting-enzyme/angiotensin-2-receptor inhibitors: 40.8 to 85.2% (P-value for-trend <0.001 for all). One-year mortality decreased from 22.1 to 14.1%. Standardized incidence ratio compared with the general population decreased from 5.54 to 3.74 (P < 0.001). Cardiovascular (CV) death decreased from 20.1 to 11.1%, myocardial infarction (MI) from 11.5 to 5.8%; stroke from 2.9 to 2.1%; heart failure from 7.1 to 6.2%. After standardization for differences in demography and baseline characteristics, the change of 1-year CV-death or MI corresponded to a linear trend of 0.915 (95% confidence interval: 0.906-0.923) per 2-year period which no longer was significant, 0.997 (0.984-1.009), after adjustment for changes in treatment. The changes in treatment and outcomes were most pronounced from 1994 to 2008. CONCLUSION: Gradual implementation of new and established evidence-based treatments in STEMI patients during the last 20 years has been associated with prolonged survival and lower risk of recurrent ischaemic events, although a plateauing is seen since around 2008.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehx515

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Key treatments 1995–2014. STEMI, ST-elevation myocardial infarction.
Figure 1 Key treatments 1995–2014. STEMI, ST-elevation myocardial infarction.CC BY-NC · PubMed Central
Figure 2 Kaplan–Meier curves for long-term outcomes in patients included from 1995–96 (dark red) to 2013–14 (dark green).
Figure 2 Kaplan–Meier curves for long-term outcomes in patients included from 1995–96 (dark red) to 2013–14 (dark green).CC BY-NC · PubMed Central
Figure 3 Odds and hazard ratios for the association between 2 years change in time-period and outcome (cardiovascular death or MI)—unadjusted and after stepwise adjustment for differences in demography, baseline characteristics, and treatments over time. CV, cardiovascular; PCI, percutaneous coronary intervention; MI, myocardial infarction.
Figure 3 Odds and hazard ratios for the association between 2 years change in time-period and outcome (cardiovascular death or MI)—unadjusted and after stepwise adjustment for differences in demography, baseline characteristics, and treatments over time. CV, cardiovascular; PCI, percutaneous coronary intervention; MI, myocardial infarction.CC BY-NC · PubMed Central
Central illustration In-hospital and 1-year outcomes. (A) Absolute rates for in-hospital (1995–2012) and 1-year outcomes (1995–2012) in each 2-year block. (B) Standardized death and MI rates for in-hospital and 1-year outcomes. MI, myocardial infarction; STEMI, ST-elevation myocardial infarction.
Central illustration In-hospital and 1-year outcomes. (A) Absolute rates for in-hospital (1995–2012) and 1-year outcomes (1995–2012) in each 2-year block. (B) Standardized death and MI rates for in-hospital and 1-year outcomes. MI, myocardial infarction; STEMI, ST-elevation myocardial infarction.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 458

Metadata

Authors
Szummer, K., Wallentin, L., Lindhagen, L., Alfredsson, J., Erlinge, D., Held, C., James, S., Kellerth, T., Lindahl, B., Ravn-Fischer, A., Rydberg, E., Yndigegn, T., & Jernberg, T.
Affiliations
  • Karolinska University Hospital (SE)
  • Uppsala University (SE)
  • Linköping University (SE)
  • Lund University (SE)
  • Örebro University Hospital (SE)
  • Department of Molecular and Clinical Medicine, Institution of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden
  • Danderyds sjukhus (SE)
Corresponding author
Szummer, Karolina
Venue
European Heart Journal
Published
2017-08-29
Volume
38
Issue
41
Pages
3056-3065
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2752734847
Cited by
443
References
35
Citations by year
2026: 31 · 2025: 42 · 2024: 44 · 2023: 58 · 2022: 60 · 2021: 67 · 2020: 48 · 2019: 58 · 2018: 29 · 2017: 6
FWCI
29.84
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Swedish Foundation for Strategic Research
  • Stockholm County Council
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
ST-elevation myocardial infarction, evidence-based treatment, treatment trends, primary percutaneous coronary intervention, reperfusion therapy, dual antiplatelet therapy, statins, beta-blockers, ACE inhibitors, angiotensin receptor blockers, one-year mortality, cardiovascular mortality, myocardial infarction, stroke, heart failure, SWEDEHEART registry, real-world outcomes
MeSH terms
ST Elevation Myocardial Infarction, Aged, Angiotensin-Converting Enzyme Inhibitors, Female, Heart Failure, Hospitalization, Humans, Male, Platelet Aggregation Inhibitors, Recurrence, Registries, Sweden, Time Factors, Treatment Outcome, Evidence-Based Medicine, Stroke, Kaplan-Meier Estimate, Angiotensin II Type 2 Receptor Blockers, Percutaneous Coronary Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. https://app.cochat.ai/papers/10.1093/eurheartj/ehx515
The paper
Szummer, K., Wallentin, L., Lindhagen, L., Alfredsson, J., Erlinge, D., Held, C., James, S., Kellerth, T., Lindahl, B., Ravn-Fischer, A., Rydberg, E., Yndigegn, T., & Jernberg, T. (2017). Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.